These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25796190)

  • 1. Effects of sarizotan in animal models of ADHD: challenging pharmacokinetic-pharmacodynamic relationships.
    Danysz W; Flik G; McCreary A; Tober C; Dimpfel W; Bizot JC; Kostrzewa R; Brown RW; Jatzke CC; Greco S; Jenssen AK; Parsons CG
    J Neural Transm (Vienna); 2015 Sep; 122(9):1221-38. PubMed ID: 25796190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal 6-OHDA lesion model in mouse induces Attention-Deficit/ Hyperactivity Disorder (ADHD)-like behaviour.
    Bouchatta O; Manouze H; Bouali-Benazzouz R; Kerekes N; Ba-M'hamed S; Fossat P; Landry M; Bennis M
    Sci Rep; 2018 Oct; 8(1):15349. PubMed ID: 30337626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sarizotan on the corticostriatal glutamate pathways.
    Antonelli T; Fuxe K; Tomasini MC; Bartoszyk GD; Seyfried CA; Tanganelli S; Ferraro L
    Synapse; 2005 Dec; 58(3):193-9. PubMed ID: 16138317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
    Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
    Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
    J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder.
    Barth V; Need AB; Tzavara ET; Giros B; Overshiner C; Gleason SD; Wade M; Johansson AM; Perry K; Nomikos GG; Witkin JM
    J Pharmacol Exp Ther; 2013 Feb; 344(2):501-10. PubMed ID: 23197772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile.
    Bartoszyk GD; Van Amsterdam C; Greiner HE; Rautenberg W; Russ H; Seyfried CA
    J Neural Transm (Vienna); 2004 Feb; 111(2):113-26. PubMed ID: 14767715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure.
    Bizot JC; David S; Trovero F
    Neurosci Lett; 2011 Feb; 489(1):20-4. PubMed ID: 21129437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors.
    Sagarduy A; Llorente J; Miguelez C; Morera-Herreras T; Ruiz-Ortega JA; Ugedo L
    Exp Neurol; 2016 Mar; 277():35-45. PubMed ID: 26687972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia.
    Rosengarten H; Bartoszyk GD; Quartermain D; Lin Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):273-9. PubMed ID: 16229932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
    Ueno K; Togashi H; Yoshioka M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder.
    Botanas CJ; Lee H; de la Peña JB; Dela Peña IJ; Woo T; Kim HJ; Han DH; Kim BN; Cheong JH
    Physiol Behav; 2016 Mar; 155():30-7. PubMed ID: 26656767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
    Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys.
    Grégoire L; Samadi P; Graham J; Bédard PJ; Bartoszyk GD; Di Paolo T
    Parkinsonism Relat Disord; 2009 Jul; 15(6):445-52. PubMed ID: 19196540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HT
    Korte SM; Prins J; Van den Bergh FS; Oosting RS; Dupree R; Korte-Bouws GA; Westphal KG; Olivier B; Denys DA; Garland A; Güntürkün O
    Eur J Pharmacol; 2017 Jan; 794():257-269. PubMed ID: 27866999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle.
    Liu YP; Huang TS; Tung CS; Lin CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():81-90. PubMed ID: 25151304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).
    Caballero M; Núñez F; Ahern S; Cuffí ML; Carbonell L; Sánchez S; Fernández-Dueñas V; Ciruela F
    Neurosci Lett; 2011 Apr; 494(1):44-8. PubMed ID: 21362462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder.
    Hiraide S; Ueno K; Yamaguchi T; Matsumoto M; Yanagawa Y; Yoshioka M; Togashi H
    Pharmacol Biochem Behav; 2013 Apr; 105():89-97. PubMed ID: 23380523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease.
    Sun YN; Wang T; Wang Y; Han LN; Li LB; Zhang YM; Liu J
    Neuropharmacology; 2015 Aug; 95():181-91. PubMed ID: 25797491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.